Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.38 AUD | -0.71% | +0.92% | +52.58% |
05-03 | Telix Pharmaceuticals Completes Acquisition of QSAM Biosciences and Drug Samarium-153-DOTMP | MT |
04-30 | Bell Potter Downgrades Telix Pharmaceuticals to Hold from Buy, Price Target is AU$14.50 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+52.58% | 3.38B | |
+26.31% | 44.96B | |
-0.90% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+9.47% | 26.08B | |
-21.29% | 19.03B | |
+6.03% | 12.75B | |
+28.51% | 12.06B | |
-3.35% | 11.75B |
- Stock Market
- Equities
- TLX Stock
- News Telix Pharmaceuticals Limited
- Telix Pharmaceuticals Mulls US IPO